{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:45:40Z","timestamp":1793353540587,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI072648"],"award-info":[{"award-number":["AI072648"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI141304"],"award-info":[{"award-number":["AI141304"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001026","name":"Central New York Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clim.2021.108781","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T03:21:36Z","timestamp":1623813696000},"page":"108781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Improvement of renal and non-renal SLE outcome measures on sirolimus therapy \u2013 A 21-year follow-up study of 73 patients"],"prefix":"10.1016","volume":"229","author":[{"given":"Paramarajan","family":"Piranavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clim.2021.108781_bb0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of Belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2021.108781_bb0010","first-page":"172.2","article-title":"OP0277 AURORA phase 3 study demonstrates Voclosporin statistical superiority over standard of Care in Lupus Nephritis (LN)","volume":"79","author":"Arriens","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2021.108781_bb0015","series-title":"Nature Reviews Rheumatology","first-page":"169","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016"},{"issue":"9","key":"10.1016\/j.clim.2021.108781_bb0020","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.22085","article-title":"Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus","volume":"54","author":"Fernandez","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"10126","key":"10.1016\/j.clim.2021.108781_bb0025","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","article-title":"Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial","volume":"391","author":"Lai","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.clim.2021.108781_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20953336","article-title":"Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis","volume":"12","author":"Peng","year":"2020","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"FEB","key":"10.1016\/j.clim.2021.108781_bb0035","article-title":"Clinical experience of sirolimus regarding efficacy and safety in systemic lupus erythematosus","volume":"10","author":"Eriksson","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.clim.2021.108781_bb0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3899\/jrheum.180507","article-title":"Longterm data on sirolimus treatment in patients with lupus nephritis","volume":"45","author":"Yap","year":"2018","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2021.108781_bb0045","series-title":"Kidney International","article-title":"The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients","volume":"49","author":"Murgia","year":"1996"},{"issue":"4","key":"10.1016\/j.clim.2021.108781_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/0961203307088289","article-title":"Rapamycin prevents the development of nephritis in lupus-prone NZB\/W F 1 mice","volume":"17","author":"Lui","year":"2008","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.clim.2021.108781_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfn216","article-title":"Rapamycin attenuates the severity of established nephritis in lupus-prone NZB\/W F1 mice","volume":"23","author":"Lui","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.clim.2021.108781_bb0060","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfq496","article-title":"The PI3K\/Akt\/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin","volume":"26","author":"Stylianou","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7253","key":"10.1016\/j.clim.2021.108781_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"issue":"AUGUST","key":"10.1016\/j.clim.2021.108781_bb0070","article-title":"Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice","volume":"5","author":"Bitto","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.clim.2021.108781_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2017.12.026","article-title":"A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: immunological, physical performance, and cognitive effects","volume":"105","author":"Kraig","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.clim.2021.108781_bb0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clim.2016.07.024","article-title":"Pathogenesis of proliferative lupus nephritis from a historical and personal perspective","volume":"185","author":"Fu","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2021.108781_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clim.2016.08.015","article-title":"A systems approach to renal inflammation in SLE","volume":"185","author":"Berthier","year":"2017","journal-title":"Clin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661621001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:05:35Z","timestamp":1761494735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661621001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":17,"alternative-id":["S1521661621001182"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108781","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of renal and non-renal SLE outcome measures on sirolimus therapy \u2013 A 21-year follow-up study of 73 patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108781"}}